摘要
目的探讨疏血通注射液对ST段抬高型急性心肌梗死(STEMI)患者急诊入院2h内的疗效。方法收集64例急诊STEMI患者,随机分为治疗组与对照组,每组各32例。对照组常规给予阿司匹林、氯吡格雷、低分子肝素等治疗;治疗组在对照组治疗的基础上加用疏血通注射液治疗,观察急诊室2h内患者症状与心电图变化情况。结果临床有效率治疗组为78.1%,对照组为53.1%,治疗组优于对照组(P<0.05)。结论疏血通注射液能有效改善再灌注治疗之前的STEMI临床症状,对STEMI的院内急救有积极辅助作用。
OBJECTIVE To discuss the effect of Shuxuetong injection on acute ST elevation myocardial infarc- tion (STEMI) patients emergency within 2 hours. METHODS Collected 64 cases of acute STEMI patients, which were divided into treatment and control groups by random, each group was 32. aspirin, clopidogrel and lowmolecular heparin were used in control group, on the basis of the control group, treatment groups combined with shuxuetong in- jection, Observed symptoms and electrocardiographic changes in patients with 2 hours in the emergency room. RESULTS In terms of clinical effectiveness , the treatment group was 78. 1%, control group was 53.1%, effect of treatment group is better than control group (P 〈 0. 05 ). CONCLUSION Shuxuetong injection can im- prove symptoms before reperfusion therapy for STEMI,which plays an important role in emergency.
出处
《海峡药学》
2017年第5期69-70,共2页
Strait Pharmaceutical Journal
基金
"重大新药创制"科技重大专项十二五第二批项目:创新药物研究开发技术平台建设-心脑血管疾病中药新药临床评价技术平台及规范研究
编号2012ZⅩ09303-010-001